Literature DB >> 16954533

Transport of bacterial toxins into target cells: pathways followed by cholera toxin and botulinum progenitor toxin.

Yukako Fujinaga1.   

Abstract

A number of bacterial toxins have sophisticated mechanisms for reaching their specific targets in mammalian cells, to exert their toxicity. This review focuses on the transport mechanisms of cholera toxin and botulinum neurotoxin complex. Cholera toxin is an ADP-ribosyltransferase toxin, and the covalent modification of heterotrimeric Gs protein in the cytosol leads to the activation of adenylyl cyclase and a sequence of events culminating in massive diarrheal disease. Here, we describe the structural features of this toxin and the transport pathway followed by this toxin from the plasma membrane to the cytosol of intestinal epithelial cells. Botulinum neurotoxin is a metalloprotease toxin that enters neurons, where it cleaves core proteins of the neuroexocytosis apparatus and elicits the inhibition of neurotransmitter release. The food-borne botulism is manifested when the neurotoxin is absorbed from the digestive tract, enters the blood stream, and reaches the cytosol of the peripheral nerves. We overview the structural organization and the long journey followed by this toxin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954533     DOI: 10.1093/jb/mvj161

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  Expression of a cholera toxin B subunit-neutralizing epitope of the porcine epidemic diarrhea virus fusion gene in transgenic lettuce (Lactuca sativa L.).

Authors:  Nguyen-Xuan Huy; Moon-Sik Yang; Tae-Geum Kim
Journal:  Mol Biotechnol       Date:  2011-07       Impact factor: 2.695

2.  Analysis of the mechanisms that underlie absorption of botulinum toxin by the inhalation route.

Authors:  Fetweh H Al-Saleem; Denise M Ancharski; Suresh G Joshi; M Elias; Ajay Singh; Zidoon Nasser; Lance L Simpson
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

3.  Effects of acetylcholinesterase inhibitor paraoxon denote the possibility of non-quantal acetylcholine release in myocardium of different vertebrates.

Authors:  Denis V Abramochkin; Anastasia A Borodinova; Leonid V Rosenshtraukh
Journal:  J Comp Physiol B       Date:  2011-07-15       Impact factor: 2.200

4.  Do complexing proteins provide mechanical protection for botulinum neurotoxins?

Authors:  Dirk Dressler; Lizhen Pan; Fereshte Adib Saberi; Hans Bigalke
Journal:  J Neural Transm (Vienna)       Date:  2019-06-06       Impact factor: 3.575

Review 5.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

6.  Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.

Authors:  Saedeh Dadgar; Zack Ramjan; Wely B Floriano
Journal:  J Med Chem       Date:  2013-03-29       Impact factor: 7.446

Review 7.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

8.  Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Authors:  Jürgen Frevert; Dirk Dressler
Journal:  Biologics       Date:  2010-12-09

9.  Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm.

Authors:  Juwan Park; Michael S Lee; Andrew R Harrison
Journal:  Clin Ophthalmol       Date:  2011-06-01

Review 10.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.